創新醫療(002173.SZ)業績預吿修正:上半年預虧1800萬元-2500萬元
格隆匯7月14日丨創新醫療(002173.SZ)披露2021年半年度業績預吿修正公吿,公司此前披露預計歸屬於上市公司股東的淨利潤變動區間-5500萬元至-4500萬元,變動幅度:-2.89%至15.81%。
修正後,預計歸屬於上市公司股東的淨利潤虧損1800萬元-2500萬元,比上年同期上升53.23 %-66.33 %。基本每股虧損0.04元/股-0.05元/股。
業績向上修正主要原因是:
報吿期內,公司收到了陳夏英支付的全部珍珠資產股權轉讓尾款,公司針對此債權計提的壞賬準備745.93萬元全部轉回;同時,公司收到了陳夏英支付的珍珠資產股權轉讓款項利息705.74萬元。
公司使用部分募集資金進行現金管理購買理財產品到期贖回,理財收益增加844.74萬元。
因報吿期內新冠疫情形勢有所緩解,醫療服務需求有所恢復,子公司建華醫院營業收入與上年同期相比略有增長,虧損金額與上年同期相比減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.